Skip to content
LeanGard®
  • Leangard®
    • Introduction
    • Mechanism of action
    • Rationale of composition
  • Research
    • Clinical evidence
  • IP Rights
    • Patents
  • Newsroom
    • Press Releases
    • Media Coverage
    • Ads
  • About Sabinsa
  • Contact Us

Sabinsa Unveils Weight Management Ingredient LeanGard®

Sabinsa Corporation is combining the forces of three of its established patented ingredients in the unveiling of a new weight management ingredient LeanGard.

The company will present LeanGard for use in dietary supplements at the Slimming Ingredients Conference in Berlin. The ingredient is commercially ready and the company said it would most likely see its first sales in the United States.

Sabinsa hopes to market the proprietary ratio of its clinically researched ingredients, Forslean, Garcitrin and Bioperine, as a branded ingredient recognizable to consumers in an increasingly competitive weight loss market.

Approximately one third of Americans are obese and Euromonitor International estimates the US weight management supplements market to be worth $3.93bn, while the European market is valued at $0.93bn in 2005.

Sabinsa wants to differentiate itself from those products that promote rapid weight loss at any physical cost for cosmetic purposes and instead highlight the body of science behind its combined ingredients.

“We’re trying to approach this from a health stand-point rather than just a superficial stand point,” Sabinsa president Todd Norton told NutraIngredients-USA.

Sabinsa’s ingredient is designed to promote lean body mass, suppress appetite and enhance thermogenic activity.

“LeanGard is a combination of three patented and clinically tested ingredients that Sabinsa has had for years and has combined into a proprietary blend to combine different facets of weight management issues,” said Norton.

ForsLean is an extract derived from Coleus forskohlii roots and helps to build lean body mass and optimize body composition through cAMP (cyclic adenosine monophosphate) activation.

Garcitrin contains calcium salt hydroxycitric acid (HCA) and garcinol, a polyisoprenylated benzophenone isolated from Garcinia cambogia and Garcinia indica. These fruits are thought to reduce fatty acid, lipid synthesis as well as to improve lean body mass.

Standardized piperine Bioperine is extracted from black pepper and has been shown to increase the absorption of nutrients in nutritional supplement formulations.

Forslean helps to build lean body mass and maintain healthy body composition through a cAMP mediated action.

While LeanGard has not been put to clinical trial yet, there is a protocol currently being designed for a weight management study, according to Norton.

“Standing alone the ingredients have all proved themselves safe and effective,” he said.

For the time being, the ingredient is geared to the US dietary supplement market due to regulatory issues.

“Right now the product is positioned as a dietary supplement but the forward view is that there may be other applications in the future,” said Norton. “It still doesn’t cross the threshold in some instances, so there’s still a little bit of work to do.”

The company would like to get Generally Recognized as Safe (GRAS) status for the ingredient for use in functional food, as well as get it through regulatory hoops for use in supplements in Europe.

Dr. Lakshmi Prakash, vice president of innovation and business development with Sabinsa, will present LeanGard Friday at Slimming Ingredients in Berlin.

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USA India
Utah, USA Japan
Australia Poland
Brasil South Korea
Canada South Africa
China Vietnam
Germany  

Contact us

    © 2022 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.